BIOTECHNOLOGY VALUE FUND L P - 31 Dec 2024 SCHEDULE 13G/A Report for 89bio, Inc. Common Stock, par value $0.001 per share (ETNB)

Filing Manager
BIOTECHNOLOGY VALUE FUND L P
Reporting Manager
BVF PARTNERS L P/IL
Security
89bio, Inc. Common Stock, par value $0.001 per share
Symbol
ETNB
Shares outstanding
120,385,694 shares
Disclosed Ownership
4,333,885 shares
Ownership
3.6%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 16:07:20 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BIOTECHNOLOGY VALUE FUND L P 1.9% 2,227,427 0 2,227,427 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF I GP LLC 1.9% 2,227,427 0 2,227,427 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BIOTECHNOLOGY VALUE FUND II LP 1.5% 1,799,517 0 1,799,517 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF II GP LLC 1.5% 1,799,517 0 1,799,517 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
Biotechnology Value Trading Fund OS LP 0.2% 223,979 0 223,979 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF Partners OS Ltd. 0.2% 223,979 0 223,979 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF GP HOLDINGS LLC 3.4% 4,026,944 0 4,026,944 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF PARTNERS L P/IL 3.6% 4,333,885 0 4,333,885 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF INC/IL 3.6% 4,333,885 0 4,333,885 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
LAMPERT MARK N 3.6% 4,333,885 0 4,333,885 /s/ Mark N. Lampert Mark N. Lampert